<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02232568</url>
  </required_header>
  <id_info>
    <org_study_id>2013P001165</org_study_id>
    <nct_id>NCT02232568</nct_id>
  </id_info>
  <brief_title>Trial of Feedback on Blood Use</brief_title>
  <acronym>TOFU</acronym>
  <official_title>Trial of Feedback on Blood Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial of Feedback on Blood Use (TOFU)

      The TOFU study will represent the first attempt to rigorously assess the impact of
      audit-feedback on changing transfusion practice. The primary hypothesis is that providing
      individual feedback on transfusion practice to orthopedic surgeons will reduce elective RBC
      transfusions in the postoperative period.

      TOFU is a two-arm, cluster-randomized controlled trial. Initially, baseline blood use data
      will be collected at all study sites. Next, the PI at each site will give a short educational
      presentation to the orthopedic surgeons. The presentation will consist of a standardized
      10-minute presentation reviewing the data from the FOCUS trial and the recommended red blood
      cell (RBC) transfusion trigger of 8 g/dL (or symptomatic anemia) based on that data. Clusters
      of orthopedic surgeons will then be randomized to either the Control arm (no feedback) or the
      Intervention arm (monthly feedback). All of the surgeons at a given site will either receive
      or not receive feedback. The feedback will take the form of emailed monthly reports detailing
      blood use by each surgeon post-hip surgery. Surgeons will be anonymized in the reports as &quot;A,
      B, C . . .&quot; but each surgeon will know which data are his own. The primary end point is the
      decrease from baseline in the proportion of patients transfused with a pretransfusion
      hemoglobin of &gt; 8 g/dL.

      TOFU will be conducted at 8 sites in Europe and North and South America. Care has been taken
      to minimize the labor and costs required to conduct this study. The only data collected will
      be: patient age/gender; procedure; surgeon (anonymized); surgery &amp; discharge dates; RBC units
      transfused; Hgb levels. The data will be entered at each site into a web-based Case Report
      Form, and will be stored centrally by the Data Coordinating Center (DCC). The DCC will
      generate monthly feedback reports and email them to each Intervention arm site PI. The site
      PI will then email the reports to each local orthopedic surgeon.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients transfused</measure>
    <time_frame>12 months</time_frame>
    <description>Decrease from baseline in the proportion of patients transfused with pretransfusion hemoglobin of &gt; 8 g/dL.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Compliance With Restrictive RBC Transfusion Guideline</condition>
  <arm_group>
    <arm_group_label>Feedback Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Orthopedic surgeons in the Feedback Arm will receive monthly reports providing individualized data on compliance with the FOCUS trial RBC transfusion guideline (pretransfusion Hb &lt;8 g/dL for hip surgery patients in the postoperative period.) Feedback data will be anonymized, but surgeons will be able to see their own data in comparison with their peers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Orthopedic surgeons in the Control Arm will not receive any feedback on their use of RBC transfusion in hip surgery patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Feedback</intervention_name>
    <arm_group_label>Feedback Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;= 18 years old undergoing total hip arthroplasty or hip hemiarthroplasty

        Exclusion Criteria:

          -  Refusal of blood transfusions

          -  Surgeons utilizing &quot;fast track&quot; protocols (planned discharge on postoperative day 1 or
             2 following surgery.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard M Kaufman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard M Kaufman, MD</last_name>
    <phone>617-732-4749</phone>
    <email>rmkaufman@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Richard Kaufman MD</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard M Kaufman, MD</last_name>
      <phone>617-732-4749</phone>
      <email>rmkaufman@partners.org</email>
    </contact>
    <investigator>
      <last_name>Richard M Kaufman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Cohn, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Claudia Cohn, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ronald Jackups MD, PhD</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Jackups, MD, PhD</last_name>
      <phone>314-362-1252</phone>
      <email>rjackups@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Ronald Jackups, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Bensalem</city>
        <state>Pennsylvania</state>
        <zip>19020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Resa Rasouli, MD</last_name>
      <email>mohammadrezarasouli@rothmaninstitute.com</email>
    </contact>
    <investigator>
      <last_name>Javad Parvizi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohammad Reza Rasoul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanhua Li, MD</last_name>
      <email>Yanhua.Li@tuhs.temple.edu</email>
    </contact>
    <investigator>
      <last_name>Yanhua Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason Hospital &amp; Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghan Delaney, DO</last_name>
      <email>meghand@pbsc.org</email>
    </contact>
    <investigator>
      <last_name>Meghan Delaney, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melanie Jorgensen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sirio Libanes</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>01308-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvano Wendel, MD, PhD</last_name>
      <email>snwendel@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Silvano Wendel, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2014</study_first_submitted>
  <study_first_submitted_qc>September 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2014</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Kaufman, Richard Max,M.D.</investigator_full_name>
    <investigator_title>Medical Director, Adult Transfusion Service</investigator_title>
  </responsible_party>
  <keyword>Patient blood management</keyword>
  <keyword>RBC transfusion</keyword>
  <keyword>Restrictive transfusion strategy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

